175 related articles for article (PubMed ID: 31001719)
1. Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation.
Nasr SS; Nasra MMA; Hazzah HA; Abdallah OY
Drug Deliv Transl Res; 2019 Oct; 9(5):968-979. PubMed ID: 31001719
[TBL] [Abstract][Full Text] [Related]
2. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
[TBL] [Abstract][Full Text] [Related]
3. Silymarin-Loaded Eudragit Nanoparticles: Formulation, Characterization, and Hepatoprotective and Toxicity Evaluation.
El-Nahas AE; Allam AN; Abdelmonsif DA; El-Kamel AH
AAPS PharmSciTech; 2017 Nov; 18(8):3076-3086. PubMed ID: 28516410
[TBL] [Abstract][Full Text] [Related]
4. Lactobionic Acid Conjugated Quercetin Loaded Organically Modified Silica Nanoparticles Mitigates Cyclophosphamide Induced Hepatocytotoxicity.
Naqvi S; Sharma H; Flora SJ
Int J Nanomedicine; 2019; 14():8943-8959. PubMed ID: 31819411
[TBL] [Abstract][Full Text] [Related]
5. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Arch Pharm Res; 2011 May; 34(5):767-74. PubMed ID: 21656362
[TBL] [Abstract][Full Text] [Related]
6. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
7. Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.
Yang KY; Hwang du H; Yousaf AM; Kim DW; Shin YJ; Bae ON; Kim YI; Kim JO; Yong CS; Choi HG
Int J Nanomedicine; 2013; 8():3333-43. PubMed ID: 24039417
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
Asgarshirazi M; Shariat M; Sheikh M
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
[TBL] [Abstract][Full Text] [Related]
9. Improving Solubility and Bioavailability of Breviscapine with Mesoporous Silica Nanoparticles Prepared Using Ultrasound-Assisted Solution-Enhanced Dispersion by Supercritical Fluids Method.
Yang G; Li Z; Wu F; Chen M; Wang R; Zhu H; Li Q; Yuan Y
Int J Nanomedicine; 2020; 15():1661-1675. PubMed ID: 32210559
[TBL] [Abstract][Full Text] [Related]
10. Lipid bilayer-coated mesoporous silica nanoparticles carrying bovine hemoglobin towards an erythrocyte mimic.
Tu J; Bussmann J; Du G; Gao Y; Bouwstra JA; Kros A
Int J Pharm; 2018 May; 543(1-2):169-178. PubMed ID: 29567198
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy.
Rezaei Harandi Z; Heidari R; Reiisi S
IEEE Trans Nanobioscience; 2023 Oct; 22(4):872-880. PubMed ID: 37022888
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Liu G; Zheng D; Tian X
Int J Pharm; 2013 Mar; 445(1-2):12-9. PubMed ID: 23384728
[TBL] [Abstract][Full Text] [Related]
14. In vitro/in vivo characterization of nanocrystalline formulation of tranilast with improved dissolution and hepatoprotective properties.
Onoue S; Yamamoto K; Kawabata Y; Yamada S
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):952-7. PubMed ID: 24055688
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant activity and hepatoprotective effect of a polysaccharide from Bei Chaihu (Bupleurum chinense DC).
Zhao W; Li JJ; Yue SQ; Zhang LY; Dou KF
Carbohydr Polym; 2012 Jun; 89(2):448-52. PubMed ID: 24750742
[TBL] [Abstract][Full Text] [Related]
16. Polyethylene Sebacate-Silymarin Nanoparticles with Enhanced Hepatoprotective Activity.
Guhagarkar SA; Shah D; Patel MD; Sathaye SS; Devarajan PV
J Nanosci Nanotechnol; 2015 Jun; 15(6):4090-3. PubMed ID: 26369016
[TBL] [Abstract][Full Text] [Related]
17. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
Lungare S; Hallam K; Badhan RK
Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
[TBL] [Abstract][Full Text] [Related]
18. Silymarin liposomes improves oral bioavailability of silybin besides targeting hepatocytes, and immune cells.
Kumar N; Rai A; Reddy ND; Raj PV; Jain P; Deshpande P; Mathew G; Kutty NG; Udupa N; Rao CM
Pharmacol Rep; 2014 Oct; 66(5):788-98. PubMed ID: 25149982
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for enhanced lidocaine skin delivery.
Nafisi S; Samadi N; Houshiar M; Maibach HI
Int J Pharm; 2018 Oct; 550(1-2):325-332. PubMed ID: 30081227
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and biopharmaceutical characterization of amorphous solid dispersion of nobiletin, a citrus polymethoxylated flavone, with improved hepatoprotective effects.
Onoue S; Nakamura T; Uchida A; Ogawa K; Yuminoki K; Hashimoto N; Hiza A; Tsukaguchi Y; Asakawa T; Kan T; Yamada S
Eur J Pharm Sci; 2013 Jul; 49(4):453-60. PubMed ID: 23707470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
